HGH 10iu

▎HGH Structure

▎HGH Research

What is the research background of HGH?

Observations of extreme body stature cases began in the mid-19th century. In 1944, Li and Evans isolated growth hormone (GH) from bovine pituitary glands, though its effects on carbohydrate, lipid, and protein metabolism were only partially understood at the time. In the late 1950s, Knobil and colleagues established the species specificity of GH, finding that only primate GH was effective in primates. In 1963, Swiss scientist Fork Handle, while treating patients with pituitary gland removal, discovered that supplementing with HGH restored indicators like basal metabolic rate to normal levels, laying the foundation for HGH anti-aging research. Following the successful cloning of the growth hormone gene, recombinant human growth hormone (rhGH) emerged in the 1980s.

What are the mechanisms of action for HGH?

Promoting Growth and Development

Effects on Bone: HGH stimulates osteoblast activity, promoting longitudinal bone growth. During childhood and adolescence, cartilage cells in the epiphyseal plates (growth plates) are particularly sensitive to HGH. By binding to the growth hormone receptor, HGH activates a series of intracellular signaling pathways. This promotes proliferation and differentiation of chondrocytes, increases synthesis and deposition of the cartilage matrix, and consequently enables continuous bone elongation. During normal growth phases, adequate HGH levels in children ensure steady height increase^[1].

Effects on Muscle: HGH promotes protein synthesis and increases muscle mass. It stimulates amino acid uptake by muscle cells, accelerating the process of amino acids entering cells to provide ample raw materials for protein synthesis. Simultaneously, HGH inhibits muscle protein breakdown, reducing muscle protein loss and thereby maintaining muscle mass and strength^[1].

Metabolic Regulation

Glucose Metabolism Regulation: HGH's effects on glucose metabolism are complex. It can reduce peripheral tissue uptake and utilization of glucose, elevating blood glucose levels in a manner similar to insulin antagonism. This occurs because HGH inhibits certain insulin signaling pathways, decreasing cellular insulin sensitivity. Conversely, HGH promotes hepatic glycogenolysis and gluconeogenesis, increasing glucose production^[2].

Fat Metabolism Regulation: HGH promotes lipolysis. It activates hormone-sensitive lipase within adipocytes, hydrolyzing fat into glycerol and fatty acids released into the bloodstream for energy. HGH also reduces the number and volume of fat cells, decreasing body fat content—particularly visceral fat in areas like the abdomen. This mechanism makes HGH effective for weight management and improving metabolic syndrome. Slater's research indicates that appropriate HGH supplementation can assist obese patients in weight loss and improve body fat distribution^[1].

Protein Metabolism Regulation: HGH promotes protein synthesis. Beyond its effects on muscle proteins, it stimulates protein synthesis in other tissues and organs such as the liver and kidneys. This maintains the normal structure and function of bodily tissues and organs, supporting growth and repair. During processes like wound healing and postoperative recovery, HGH's role in promoting protein synthesis is particularly crucial, accelerating the repair and regeneration of damaged tissues^[1].

Cell Differentiation and Regeneration: HGH plays a vital role in cellular differentiation and regeneration. It promotes the differentiation of various cell types, such as guiding bone marrow stem cells toward hematopoietic cell differentiation to maintain normal blood production. During tissue repair, HGH stimulates cell proliferation and regeneration at injury sites, accelerating wound healing. Following skin injury, HGH promotes proliferation of epidermal cells and fibroblasts, facilitating synthesis of extracellular matrix components like collagen to hasten wound closure and minimize scar formation^[1].

Mechanism of action at the molecular level: From a molecular biology perspective, the binding of HGH to the growth hormone receptor (GHR) on its target cell surface initiates its action. This binding induces GHR dimerization, which in turn activates receptor-associated tyrosine kinase (JAK2). JAK2 phosphorylates multiple tyrosine residues on GHR, providing binding sites for signaling molecules containing SH2 domains. This activates a cascade of downstream signaling pathways, including the JAK-STAT pathway, PI3K-AKT pathway, and MAPK pathway. These pathways regulate diverse biological processes such as cell proliferation, differentiation, and metabolism, ultimately mediating the various physiological functions of HGH^[2].

What are the applications of HGH?

Applications in Bone and Cartilage

Promoting Bone Remodeling: rHGH plays a crucial role in bone remodeling. Bone is a dynamic tissue undergoing constant metabolism, and rHGH participates in and drives this process, helping maintain normal bone structure and function^[1].

Influencing Cartilage Differentiation and Regeneration: rHGH not only acts on bones but also significantly impacts cartilage differentiation and regeneration. During growth and development, normal cartilage differentiation and regeneration are crucial for skeletal growth. rHGH promotes the proliferation and differentiation of chondrocytes, thereby influencing bone growth and development ^[1].

Applications in Growth and Development

Treatment of Pediatric Growth Hormone Deficiency: For children with short stature due to growth hormone deficiency, rHGH replacement therapy is a vital treatment. Supplementing with exogenous rHGH effectively promotes growth, helping children achieve normal height levels. According to Gasco's research, appropriate use of rHGH in treating children with growth hormone deficiency significantly increases their height gain rate and improves final height^[3].

Improving Growth in Children with Idiopathic Short Stature: Idiopathic short stature refers to a growth disorder where height is more than 2 standard deviations below the average for age, sex, and ethnicity, without underlying disease. rHGH therapy can moderately increase growth rates in these children, bringing their height closer to the normal range.

Applications in Body Composition and Metabolism

Improving Body Composition: In treating adult growth hormone deficiency, rHGH positively impacts body composition. It increases muscle mass, reduces fat accumulation, and elevates basal metabolic rate. Adults with growth hormone deficiency due to disease or other causes often experience enhanced muscle strength, reduced body fat percentage, and improved overall physical appearance and function following rHGH therapy^[3].

Regulating Metabolic Functions: rHGH participates in regulating carbohydrate, lipid, and protein metabolism in the human body. It promotes protein synthesis, aiding in maintaining normal physiological functions and tissue repair. It also regulates lipid metabolism by promoting lipolysis and reducing fat storage. Regarding carbohydrate metabolism, while rHGH may exert some influence on blood glucose levels, when used appropriately, it helps maintain glucose stability and demonstrates efficacy for certain specific metabolic disorders.

Potential Applications in Cardiovascular Health

Influencing Cardiovascular Risk Factors: Studies indicate that rHGH therapy may improve certain cardiovascular risk factors. It may help lower lipid levels, reducing the risk of atherosclerosis; it may also positively influence vascular endothelial function, maintaining normal vasodilation and contraction^[3].

Conclusion

As a vital human hormone, HGH plays a central role in growth, development, and metabolic regulation. It promotes bone growth and muscle synthesis, regulates glucose, lipid, and protein metabolism, and participates in immune enhancement and tissue repair.

About The Author

The above-mentioned materials are all researched, edited and compiled by Cocer Peptides.

Scientific Journal Author

Valentina Gasco is a researcher at the Division of Endocrinology, Diabetes and Metabolism, Department of Medical Sciences, University of Turin, Italy. She has been engaged in clinical and translational research in endocrinology, focusing on pituitary disorders, adult growth hormone deficiency (GHD), and related metabolic diseases. She has published extensively on topics such as the management of adult GHD, growth hormone replacement therapy in patients with pituitary tumors, and post-traumatic hypopituitarism, providing valuable insights for clinical practice and guideline development, and holds a recognized presence in the international scientific community. Valentina Gasco is listed in the reference of citation [3].

▎Relevant Citations

[1] Slater GL. HGH and Cartilage.; 2021.DOI:10.37191/MAPSCI-2582-385X-3(4)-077. https://api.semanticscholar.org/CorpusID:236561221.

[2] Kopchick JJ. Discovery and mechanism of action of pegvisomant. European Journal of Endocrinology 2003; 148 Suppl 2: S21-S25.DOI: 10.1530/eje.0.148s021.

[3] Gasco V, Caputo M, Lanfranco F, Ghigo E, Grottoli S. Management of GH treatment in adult GH deficiency. Best Practice & Research Clinical Endocrinology & Metabolism 2017; 31(1): 13-24.

ALL ARTICLES AND PRODUCT INFORMATION PROVIDED ON THIS WEBSITE ARE SOLELY FOR INFORMATION DISSEMINATION AND EDUCATIONAL PURPOSES.  

The products provided on this website are intended exclusively for in vitro research. In vitro research (Latin: *in glass*, meaning in glassware) is conducted outside the human body. These products are not pharmaceuticals, have not been approved by the U.S. Food and Drug Administration (FDA), and must not be used to prevent, treat, or cure any medical condition, disease, or ailment. It is strictly prohibited by law to introduce these products into the human or animal body in any form.